RHO Ventures VI LP 13D/13G Filings for Cara Therapeutics, Inc. (CARA)

RHO Ventures VI LP 13D and 13G filings for Cara Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
11:35 am
Sale		 2021-12-31 13G Cara Therapeutics, Inc.
CARA		 RHO Ventures VI LP 22
0.000%		 -77,730decrease
(-99.97%)		 Filing
2021-02-12
3:42 pm
Sale		 2020-12-31 13G Cara Therapeutics, Inc.
CARA		 RHO Ventures VI LP 77,752
5.600%		 -10,944decrease
(-12.34%)		 Filing